NOVEMBER 2021
Greetings!

Welcome to the latest issue of DNA Script's enewsletter, The Transcript, where we'll keep you regularly updated on all things DNA on demand.
NEW VIDEOS
PRODUCT: See How Simple It is to Print DNA on Your Benchtop
If you haven't seen a demo of our SYNTAX System, this short video captures both the simplicity and power of our Enzymatic DNA Synthesis (EDS) technology and DNA on demand.
WEBINAR: Custom Library Adaptors Via Enzymatic DNA Synthesis Improve Precision
of Real-Time Nanopore Sequencing
Check out this webinar where Tim Mercer, Ph.D. (Garvin Institute, Australia) describes using SYNTAX to build novel, custom library adaptors (CAPTORS) containing functional sequence elements that can measure the qualitative and quantitative accuracy of a DNA sequencing library.
NEW TECHNICAL RESOURCES
SARS-CoV-2 Spike Protein Mutagenesis Application Note
Own your workflow! In the midst a global synthetic DNA supply bottleneck, primers produced with EDS technology enabled a site-directed mutagenesis strategy for the production of optimized and variant SARS-CoV-2 spike protein expression plasmids.
SARS-CoV-2 Amplicon Sequencing Application Note
Read how DNA on demand accelerated primer production for whole-genome amplicon sequencing and the iterative cycle of design-build-test for the phylogenetic analysis of SARS-CoV-2 isolates using the ARTIC network protocol.
IN THE NEWS
Clearing the Way for a Synthetic Biology Tipping Point
Research and development in synthetic biology still faces some key bottlenecks, and the most important of these is the lack of access to high-quality, affordable, on-demand synthetic DNA—the material backbone of all of synthetic biology. ...
DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers
with $2.2M Grant Award from the NHGRI
DNA Script aims to develop a benchtop instrument using EDS to enable in-house synthesis of high-quality long oligos in a high-multiplex format in less than a day. ...
DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate
Commercialization of Enzymatic DNA Printing Platform
New funding, targeted to accelerate application expansion and platform commercialization, brings total amount raised to date to $280 million. ...
For Research Use Only. Not for use in diagnostic procedures.
You are receiving this email because of your work in molecular biology and genomics applications.
If you no longer want to receive emails from DNA Script, click Unsubscribe below.